Amass
ChatGPT pluginLife sciences intelligence
- Featured
- No
not on the featured shelf
Movement
From our daily snapshots over the last 30 days.
Rank by placement
Rank in Education & research
In its category
How this plugin compares with others in the same category. Positions are counted within the category, not across the whole directory.
Education & research53rd of 402 by placement
| # | Plugin | Position | 7d |
|---|---|---|---|
| 50 | #628 | 44places down | |
| 51 | #647 | 21places down | |
| 52 | #649 | 7places down | |
| 53 | #655 | 49places down | |
| 54 | #692 | 9places up | |
| 55 | #707 | 269places up | |
| 56 | #709 | 43places down |
Also on other marketplaces
Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.
Example prompts
- “Map the current landscape for oral GLP-1 agonists in obesity — what's approved, what's in trials, and who holds patents.”
- “Make the case for and against KRAS G12D as a drug target: biology, what's been tried clinically, and failures.”
- “What happened to semaglutide since first approval — indication expansions, label changes, safety signals, and literature.”
- Categories
- Made by
- Amass Technologies ApS · Website
- Sign-in
- On Install
- Availability
- Available
- Version
- 7.0.0
- Created
- June 4, 2026
- More info